Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.94% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Financials | 0.79% |
| 5 | Healthcare | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHT
11251
DELISTED
Pioneer High Income Fund
PHT
| $193K | ﹤0.01% |
23,808
+7,874
| +49% | +$60.9K |
|
11252
PUT
ThredUp
TDUP
$352M
| $192K | ﹤0.01% |
25,700
-248,300
| -91% | -$1.46M |
|
11253
PUT
Columbus McKinnon
CMCO
$531M
| $192K | ﹤0.01% |
+12,600
| New | +$193K |
|
11254
CALL
The Honest Company
HNST
$618M
| $192K | ﹤0.01% |
37,800
-499,800
| -93% | -$2.4M |
|
11255
PUT
Seres Therapeutics
MCRB
$49.7M
| $192K | ﹤0.01% |
17,300
+16,055
| +1,290% | +$141K |
|
|
EIC
11256
Eagle Point Income Company
EIC
$231M
| $192K | ﹤0.01% |
+14,043
| New | +$194K |
|
|
NPKI
11257
CALL
NPK International
NPKI
$1.15B
| $191K | ﹤0.01% |
+22,500
| New | +$165K |
|
11258
Global X S&P 500 Risk Managed Income ETF
XRMI
$49.6M
| $191K | ﹤0.01% |
+10,686
| New | +$191K |
|
11259
Ironwood Pharmaceuticals
IRWD
$701M
| $191K | ﹤0.01% |
265,959
-382,308
| -59% | -$300K |
|
11260
CALL
Playboy Inc
PLBY
$144M
| $191K | ﹤0.01% |
117,700
-61,600
| -34% | -$79.2K |
|
11261
PUT
Verastem
VSTM
$668M
| $190K | ﹤0.01% |
45,900
+14,200
| +45% | +$89K |
|
|
THTX
11262
DELISTED
Theratechnologies
THTX
| $190K | ﹤0.01% |
+80,674
| New | +$198K |
|
|
PMF
11263
DELISTED
PIMCO Municipal Income Fund
PMF
| $190K | ﹤0.01% |
23,849
+11,467
| +93% | +$92.4K |
|
|
SY
11264
So-Young International
SY
$233M
| $190K | ﹤0.01% |
61,376
+26,198
| +74% | +$25.8K |
|
11265
WidePoint Corp
WYY
$102M
| $190K | ﹤0.01% |
55,565
+25,198
| +83% | +$90.3K |
|
11266
Skillful Craftsman
EDTK
$14.6M
| $190K | ﹤0.01% |
228,836
-7,642
| -3% | -$7.37K |
|
|
FLC
11267
Flaherty & Crumrine Total Return Fund
FLC
$173M
| $189K | ﹤0.01% |
+11,141
| New | +$183K |
|
|
ZBIO
11268
Zenas BioPharma
ZBIO
$2.13B
| $189K | ﹤0.01% |
19,541
+904
| +5% | +$8.8K |
|
|
OGCP
11269
Empire State Realty Series 60
OGCP
$1.32B
| $189K | ﹤0.01% |
22,503
+1,150
| +5% | +$8.76K |
|
11270
Tenaya Therapeutics
TNYA
$156M
| $189K | ﹤0.01% |
308,906
+181,946
| +143% | +$92.6K |
|
|
OBE
11271
PUT
Obsidian Energy
OBE
$788M
| $189K | ﹤0.01% |
34,000
-25,800
| -43% | -$128K |
|
|
ALMU
11272
Aeluma Inc
ALMU
$255M
| $189K | ﹤0.01% |
+11,526
| New | +$138K |
|
11273
CALL
Vir Biotechnology
VIR
$1.91B
| $188K | ﹤0.01% |
37,400
-36,000
| -49% | -$193K |
|
11274
Outlook Therapeutics
OTLK
$156M
| $188K | ﹤0.01% |
117,769
+46,847
| +66% | +$74.7K |
|
11275
PUT
Adtran
ADTN
$635M
| $188K | ﹤0.01% |
+21,000
| New | +$168K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.